- recruitingPHASE1, PHASE2
A Modular Phase 1/2 Study With CT7439 in Participants With Solid Malignancies
This study is testing a new medicine, CT7439, for people with solid tumours (cancers). Doctors want to see if it's safe and how well it works, both by itself and with other cancer treatments. It's an early-stage study to find the right dose.
United States · United Kingdom - active not recruitingPHASE1
Durvalumab With or Without Tremelimumab in Advanced Incurable Solid Malignancies Given With or Without Standard Chemotherapy Regimens
This study is looking for the right dose of new cancer medicines, durvalumab and tremelimumab, given with or without standard chemotherapy, for advanced solid cancers. It aims to find a dose that helps treat cancer without causing very severe side effects.
Canada